Annual Accounts Payable:
$140.34M-$28.60M(-16.93%)Summary
- As of today, CRL annual accounts payable is $140.34 million, with the most recent change of -$28.60 million (-16.93%) on December 31, 2024.
- During the last 3 years, CRL annual accounts payable has fallen by -$57.79 million (-29.17%).
- CRL annual accounts payable is now -31.85% below its all-time high of $205.91 million, reached on December 31, 2022.
Performance
CRL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Payable:
$169.62M+$23.82M(+16.34%)Summary
- As of today, CRL quarterly accounts payable is $169.62 million, with the most recent change of +$23.82 million (+16.34%) on September 27, 2025.
- Over the past year, CRL quarterly accounts payable has increased by +$33.65 million (+24.75%).
- CRL quarterly accounts payable is now -24.94% below its all-time high of $225.98 million, reached on March 26, 2022.
Performance
CRL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CRL Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -16.9% | +24.8% |
| 3Y3 Years | -29.2% | -6.6% |
| 5Y5 Years | +25.9% | +75.3% |
CRL Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -31.9% | at low | -17.6% | +41.3% |
| 5Y | 5-Year | -31.9% | +25.9% | -24.9% | +75.3% |
| All-Time | All-Time | -31.9% | +1410.5% | -24.9% | +2028.7% |
CRL Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $169.62M(+16.3%) |
| Jun 2025 | - | $145.80M(-2.4%) |
| Mar 2025 | - | $149.33M(+6.4%) |
| Dec 2024 | $140.34M(-16.9%) | $140.34M(+3.2%) |
| Sep 2024 | - | $135.96M(+2.2%) |
| Jun 2024 | - | $133.10M(+2.6%) |
| Mar 2024 | - | $129.68M(-23.2%) |
| Dec 2023 | $168.94M(-18.0%) | - |
| Dec 2023 | - | $168.94M(+23.9%) |
| Sep 2023 | - | $136.34M(-2.8%) |
| Jun 2023 | - | $140.20M(+16.8%) |
| Mar 2023 | - | $120.00M(-41.7%) |
| Dec 2022 | $205.91M(+3.9%) | $205.91M(+13.4%) |
| Sep 2022 | - | $181.63M(-14.1%) |
| Jun 2022 | - | $211.38M(-6.5%) |
| Mar 2022 | - | $225.98M(+14.1%) |
| Dec 2021 | $198.13M(+61.8%) | $198.13M(+54.9%) |
| Sep 2021 | - | $127.91M(+15.3%) |
| Jun 2021 | - | $110.93M(-12.7%) |
| Mar 2021 | - | $127.13M(+3.8%) |
| Dec 2020 | $122.47M(+9.8%) | $122.47M(+26.6%) |
| Sep 2020 | - | $96.76M(+16.6%) |
| Jun 2020 | - | $82.98M(-19.2%) |
| Mar 2020 | - | $102.70M(-7.9%) |
| Dec 2019 | $111.50M(+68.3%) | $111.50M(+4.0%) |
| Sep 2019 | - | $107.23M(+7.9%) |
| Jun 2019 | - | $99.38M(+26.6%) |
| Mar 2019 | - | $78.52M(+18.5%) |
| Dec 2018 | $66.25M(-14.9%) | $66.25M(-14.8%) |
| Sep 2018 | - | $77.74M(+15.2%) |
| Jun 2018 | - | $67.48M(-8.2%) |
| Mar 2018 | - | $73.48M(-5.6%) |
| Dec 2017 | $77.84M(+13.7%) | $77.84M(+17.5%) |
| Sep 2017 | - | $66.23M(+2.4%) |
| Jun 2017 | - | $64.65M(+6.0%) |
| Mar 2017 | - | $60.99M(-10.9%) |
| Dec 2016 | $68.48M(+86.7%) | $68.48M(+4.1%) |
| Sep 2016 | - | $65.81M(-0.6%) |
| Jun 2016 | - | $66.20M(+50.8%) |
| Mar 2016 | - | $43.90M(+19.7%) |
| Dec 2015 | $36.67M(+8.5%) | $36.67M(+16.0%) |
| Sep 2015 | - | $31.63M(-4.1%) |
| Jun 2015 | - | $32.97M(-5.5%) |
| Mar 2015 | - | $34.90M(+3.2%) |
| Dec 2014 | $33.81M(+6.4%) | $33.81M(+22.8%) |
| Sep 2014 | - | $27.55M(-21.8%) |
| Jun 2014 | - | $35.22M(-0.1%) |
| Mar 2014 | - | $35.25M(+11.0%) |
| Dec 2013 | $31.77M(+1.8%) | $31.77M(+7.1%) |
| Sep 2013 | - | $29.68M(-20.4%) |
| Jun 2013 | - | $37.30M(+19.2%) |
| Mar 2013 | - | $31.28M(+0.2%) |
| Dec 2012 | $31.22M | $31.22M(+12.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $27.74M(-19.6%) |
| Jun 2012 | - | $34.49M(+6.6%) |
| Mar 2012 | - | $32.35M(-5.8%) |
| Dec 2011 | $34.33M(+12.1%) | $34.33M(-0.8%) |
| Sep 2011 | - | $34.62M(+4.6%) |
| Jun 2011 | - | $33.09M(-0.9%) |
| Mar 2011 | - | $33.38M(+9.0%) |
| Dec 2010 | $30.63M(-1.9%) | $30.63M(-7.4%) |
| Sep 2010 | - | $33.07M(+11.4%) |
| Jun 2010 | - | $29.68M(-11.4%) |
| Mar 2010 | - | $33.51M(+7.3%) |
| Dec 2009 | $31.23M(-22.9%) | $31.23M(-12.9%) |
| Sep 2009 | - | $35.84M(-2.0%) |
| Jun 2009 | - | $36.57M(-1.9%) |
| Mar 2009 | - | $37.28M(-8.0%) |
| Dec 2008 | $40.52M(+10.4%) | $40.52M(+11.4%) |
| Sep 2008 | - | $36.37M(-16.4%) |
| Jun 2008 | - | $43.52M(+18.4%) |
| Mar 2008 | - | $36.77M(+0.2%) |
| Dec 2007 | $36.72M(+30.1%) | $36.72M(+1.9%) |
| Sep 2007 | - | $36.01M(+0.9%) |
| Jun 2007 | - | $35.71M(-4.2%) |
| Mar 2007 | - | $37.26M(+32.0%) |
| Dec 2006 | $28.22M(-1.8%) | $28.22M(+19.2%) |
| Sep 2006 | - | $23.68M(-11.7%) |
| Jun 2006 | - | $26.81M(-21.4%) |
| Mar 2006 | - | $34.13M(+18.8%) |
| Dec 2005 | $28.73M(+0.2%) | $28.73M(+11.5%) |
| Sep 2005 | - | $25.75M(+5.8%) |
| Jun 2005 | - | $24.35M(-7.8%) |
| Mar 2005 | - | $26.40M(-7.9%) |
| Dec 2004 | $28.67M(+47.5%) | $28.67M(+85.1%) |
| Sep 2004 | - | $15.49M(-5.9%) |
| Jun 2004 | - | $16.45M(+1.4%) |
| Mar 2004 | - | $16.23M(-16.5%) |
| Dec 2003 | $19.43M(+48.5%) | $19.43M(+56.1%) |
| Sep 2003 | - | $12.45M(-2.5%) |
| Jun 2003 | - | $12.77M(+1.4%) |
| Mar 2003 | - | $12.59M(-3.8%) |
| Dec 2002 | $13.08M(-5.7%) | $13.08M(+19.8%) |
| Sep 2002 | - | $10.92M(-10.8%) |
| Jun 2002 | - | $12.24M(+3.9%) |
| Mar 2002 | - | $11.78M(-15.1%) |
| Dec 2001 | $13.87M(+28.8%) | $13.87M(+47.4%) |
| Sep 2001 | - | $9.41M(-1.0%) |
| Jun 2001 | - | $9.50M(-12.1%) |
| Mar 2001 | - | $10.81M(+0.4%) |
| Dec 2000 | $10.77M(+15.9%) | $10.77M(+35.1%) |
| Sep 2000 | - | $7.97M(-8.3%) |
| Jun 2000 | - | $8.69M(-11.0%) |
| Mar 2000 | - | $9.77M |
| Dec 1999 | $9.29M(-20.0%) | - |
| Dec 1998 | $11.62M | - |
FAQ
- What is Charles River Laboratories International, Inc. annual accounts payable?
- What is the all-time high annual accounts payable for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. annual accounts payable year-on-year change?
- What is Charles River Laboratories International, Inc. quarterly accounts payable?
- What is the all-time high quarterly accounts payable for Charles River Laboratories International, Inc.?
- What is Charles River Laboratories International, Inc. quarterly accounts payable year-on-year change?
What is Charles River Laboratories International, Inc. annual accounts payable?
The current annual accounts payable of CRL is $140.34M
What is the all-time high annual accounts payable for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high annual accounts payable is $205.91M
What is Charles River Laboratories International, Inc. annual accounts payable year-on-year change?
Over the past year, CRL annual accounts payable has changed by -$28.60M (-16.93%)
What is Charles River Laboratories International, Inc. quarterly accounts payable?
The current quarterly accounts payable of CRL is $169.62M
What is the all-time high quarterly accounts payable for Charles River Laboratories International, Inc.?
Charles River Laboratories International, Inc. all-time high quarterly accounts payable is $225.98M
What is Charles River Laboratories International, Inc. quarterly accounts payable year-on-year change?
Over the past year, CRL quarterly accounts payable has changed by +$33.65M (+24.75%)